Clinical Trial

Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy

Study acronym: REDENP
Recruiting
View on ClinicalTrials.gov →
Summary
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a common condition causing nasal congestion, discharge, and reduced sense of smell, seriously affecting patients' quality of life. A subtype called eosinophilic CRSwNP (eCRSwNP) is difficult to treat and often recurs after surgery. Currently, diagnosing this subtype requires tissue samples after surgery, which delays treatment decisions and may lead to unnecessary surgeries. Our research team has developed a new, non-invasive diagnostic system using advanced spectral technology to detect a natural fluorescence marker inside eosinophils (a type of immune cell) in nasal polyps. This system can quickly identify eCRSwNP before surgery by shining a safe light on the nasal tissue and analyzing the fluorescence signals. This study aims to evaluate how accurate and safe this real-time diagnostic system is in clinical practice. If successful, it will help doctors choose better personalized treatments, reduce unnecessary surgeries, lower recurrence rates, and ultimately improve patients' lives.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-10.
Status change: Not Yet Recruiting → Recruiting 2025-12-23
Trial Details
NCT Number NCT07125586
Lead Sponsor The Affiliated Hospital of Qingdao University
Conditions Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Enrollment 353 participants
Start Date 2025-08-26
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-06-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-30